In one of the opening sessions of the Veeva Commerical Summit 2014, cloud-based life sciences provider Veeva's co-founder and president Matt Wallach asserted that “transparency” will force you to understand your cause better, and that will be good for the industry.”
Transparency was the hot topic in a round-table on disclosure between pharma legal experts, a compliance specialist and pharma IT specialist.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze